This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Link between effectiveness and cost data
The costing was carried out prospectively on the same sample of patients as that used in the effectiveness study.
Study sample
Power calculations, to assure a certain power, were performed in the planning phase of the study. A sample size of 16 patients in each group was required to assure 0.80 power (two-tailed alpha-error of 0.05 and a beta-error of 0.20) in the detection of a 15-minute difference in the time to discharge from the post-anaesthesia care unit between those receiving the GA and those receiving the PNB.
Forty patients were initially included in the study. These were randomly allocated to receive either a propofolremifentanil-based GA (n=20) or a combined sciatic-femoral nerve block (PNB group, n=20) The mean age of the patients was 51 years in the GA group and 46 years in the PNB group. There were 7 (GA group) and 9 (PNB group) women, respectively, in the two groups. One patient was excluded from the analysis because of hospital admission for surgical problems. Therefore, the final study sample comprised 39 patients (20 in the GA group and 19 in the PNB group).
The authors did not report any evidence that the study sample was representative of the study population.
Study design
This was a randomised controlled trial that was conducted in a single centre. The duration of follow-up was one day after discharge. The patients were randomised to the groups using a computer-generated random table. The outcome assessment does not appear to have been blinded, although the authors stated that an independent observer was responsible for the evaluation of the patients until discharge.
Analysis of effectiveness
The analysis of the clinical study was conducted on an intention to treat basis. The primary health outcomes assessed were: the median preparation time (i.e. time from IV premedication to skin disinfection), the median discharge times (and their associated ranges), side effects (i.e. hypotension after induction and chest rigidity), the number and percentage of patients experiencing pain intensity during surgery, and pain intensity using a visual analogue scale (VAS).
After surgery, the modified Aldrete's score and pain intensity were assessed every 5 minutes. When the vital signs remained stable for two subsequent measurements (and the modified Aldrete's score was 9 and the VAS for pain intensity was less than 30 mm), the patients were transferred to the day-surgery unit where they were evaluated every 30 minutes by an independent observer until they were judged ready to go home. The criteria for discharge were patient alert, stable vital signs, patient able to void and ambulate, nausea and pain controlled by oral medication, and patient had nerve block resolution.
The costs of personnel relating to time spent in the PACU were lower for the PNB group (Euro 1.10, range: 0 -22) than in the GA group (Euro 30, range: 0 -176), (p=0.0005).
There were no significant differences in the median total costs per patient between the anaesthetic procedures. The median cost was Euro 158 (range: 105 -194) per PNB patient versus Euro 160 (range: 101 -238) per GA patient, (p=0.61).
Synthesis of costs and benefits
A synthesis of the costs and benefits was not relevant as a cost-consequences analysis was carried out.
Authors' conclusions
Compared with a propofol-remifentanil general anaesthetic (GA) technique, the combined sciatic-femoral nerve block was an effective technique in patients undergoing outpatient arthroscopy. The combined sciatic-femoral nerve block may provide similar intraoperative analgesic efficacy to the GA procedure, a shorter length of stay in the postanaesthesia care unit (PACU), and an increased likelihood of bypassing the first phase of postoperative recovery. No conclusion about the costs was drawn.
CRD COMMENTARY -Selection of comparators
The choice of the comparator (combined sciatic-femoral nerve block procedure) was justified as it represented the routine anaesthesia technique used for knee arthroscopy in the authors' setting. You should decide whether it represents a valid comparator in your own setting.
Validity of estimate of measure of effectiveness
A randomised controlled study was performed, which was appropriate for the study question. Power calculations were carried out and these justified the size of the sample used in the study. The authors stated that the study groups were comparable at baseline, therefore few confounding factors may be present. It was not reported whether the investigators were blinded to the allocation of the patients to the study groups. Assessment biases could therefore have occurred, and these might have had some impact on the results of the analysis. Since the data came from a single centre, the patients included in this study might not be representative of the study population. This may hinder the generalisability of the results to other settings. Statistical analyses were undertaken to compare health outcomes between the groups.
